rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Ranbaxy Lab

Rediff.com  »  News  »   Ranbaxy Lab

  News for Ranbaxy Lab

  • News
  • Business

'Shortage of Tamiflu, masks won't be tolerated'

The Union Health Ministry on Wednesday told the state governments to crack down on people hoarding and black-marketing swine flu drug Oseltamivir and masks used as protection against the disease,......

Nuclear plants secure, says former chief

Dr M R Srinivasan, former chairman of India's Atomic Energy Commission, believes India's nuclear reactors, spread along the country's coastline, are secure against the threat of terrorist strikes.......

Explained: Sino-Indian ties in figures

On January 13, Prime Minister Manmohan Singh will reach Beijing with issues related to business and economy on his mind. The Chinese economy is roughly three times bigger than India's. The overview......

Ranbaxy Lab shares zoom nearly 29%; m-cap rises by Rs 3,279 cr

Continuing its initial rally, shares of drug major Ranbaxy Laboratories on Thursday surged nearly 29 per cent, adding Rs 3,279 crore (Rs 32.79 billion) to its market value, after the company......

Ranbaxy Lab dips nearly 7% on bourses

Shares of Ranbaxy Laboratories on Monday dipped by nearly 7 per cent on reports that the company's manufacturing facility at Mohali has come under the US Food and Drug Administration's scanner.......

Drug firms go slow on patent challenges

Pharmaceutical majors like Ranbaxy, Dr Reddy's Lab, Wockhardt, Glenmark and Sun Pharma are now treading a careful patent litigation path in the US market to expand their generic business instead of......

Indian pharma giants change tactics

Indian pharmaceutical majors, such as Ranbaxy Lab and Dr Reddy's, are changing their tactics to concentrate on brand acquisitions and strategic investments rather than risky big ticket cross-border......

WHO drops 3 Ranbaxy AIDS drugs

World Health Organization on Thursday said that three AIDS drug manufactured by Ranbaxy Lab would be removed fromits list of prequalified products for being non-compliant with international......

  People speak for ranbaxy lab

  • QNA
suresh
Q. I HOLD RANBAXY LAB. SHARES WILL GUIDE MAY I HOLD OR SALE
Suresh:  A.  more

http://qna.rediff.com/questions-and-answers/i-hold-ranbaxy-lab.-shares-will-guide-may-i-hold-or-sale/21287411/answers/

suresh
Q. I had purchased 10 units of Ranbaxy Labs at 400.43. Ranbaxy Labs is currently trading at around 463. Should I sell now or I should wait for some more time.
Suresh:  A. ROCKING STOCK CALLS THROUGH SMS......SEND UR MOBILE NO. TO SUREPROFITS@REDIFFMAIL.COM..... GET FREE TRAIL. more

http://qna.rediff.com/questions-and-answers/i-had-purchased-10-units-of-ranbaxy-labs-at-400.43.-ranbaxy-/21287411/answers/17460252

Soumyajit Basu Mallik
Q. What is target for Ranbaxy in June 2010?
Soumyajit Basu Mallik:  A. RANBAXY LABS looks good to touch 600-620 by Jan 2011. Throughout last year e had seen skeletons tumbling for this stop, but of late it has settled...... more

http://qna.rediff.com/questions-and-answers/what-is-target-for-ranbaxy-in-june-2010/17459387/answers/17146146

Muthu Kumar
Q. Buy Ranbaxy in this level, it looks gud
Muthu Kumar:  A. what is the target level of Ranbaxy Lab more

http://qna.rediff.com/questions-and-answers/buy-ranbaxy-in-this-level-it-looks-gud/17074426/answers/16755971

  Web results for Ranbaxy Lab
New NPPA notification on 43 formulations to hit sales by 33% and trade margin by 6%

With the NPPA September 15 notification, capping the prices of 43 formulations, which includes gastro-intestinal, anti-infectives drugs and... ...

http://www.pharmabiz.com/NewsDetails.aspx?aid=84183&sid=1
Indian pharma could gain from China-India MoUs

MoUs aimed at facilitating market access, cooperation on drug regulations could increase inroads into China pharma market Pharmaceutical products... ...

http://pharma.financialexpress.com/latest-updates/4435-indian-pharma-could-gain-from-china-india-mous
Price cuts announced by NPPA to hit Ranbaxy, Cipla the most

New Delhi|Mumbai: Ranbaxy Labs and Cipla are among the companies which would face the maximum brunt of the new price cuts announced by National... ...

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/price-cuts-announced-by-nppa-to-hit-ranbaxy-cipla-the-most/articleshow/42841149.cms
Pharma majors to be hit as drug regulator caps prices

In a move that might impact major drug makers such as Ranbaxy, Cipla, Cadila Health, and Lupin, the National Pharmaceutical Pricing Authority... ...

http://www.business-standard.com/article/companies/pharma-majors-to-be-hit-as-drug-regulator-caps-prices-114091801524_1.html
Ranbaxy Lab receives Civil Investigative Demand from United States Department of Justice

The CID is a request for documents and information, and is not an allegation of wrongdoing or demand for compensation. Ranbaxy Laboratories Ltd has... ...

http://www.indiainfoline.com/article/news-sector-pharma-healthcare/ranbaxy-lab-receives-civil-investigative-demand-from-united-states-department-of-justice-114091800016_1.html

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z